ANTIPLATELET DURATION STRATEGIES AFTER PERCUTANEOUS CORONARY INTERVENTION WITH STENTING: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Leonardo Knijnik,Marcelo Fernandes,Manuel Rivera Maza,Vanessa Blumer,Rhanderson Cardoso,Abhinav Goyal,Michael C. McDaniel,Henry A. Liberman,Laurence S. Sperling,Mauricio G. Cohen

ANTIPLATELET DURATION STRATEGIES AFTER PERCUTANEOUS CORONARY INTERVENTION WITH STENTING: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

2020

Leonardo Knijnik
Marcelo Fernandes
Manuel Rivera Maza
Vanessa Blumer
Rhanderson Cardoso
Abhinav Goyal
Michael C. McDaniel
Henry A. Liberman
Laurence S. Sperling
Mauricio G. Cohen

The optimal antiplatelet duration after percutaneous coronary intervention (PCI) with stenting is not completely understood. PubMed, Scopus, and Cochrane Central were searched for randomized controlled trials (RCTs) comparing antiplatelet duration strategies after PCI. The outcomes of interest were

Keywords:

Diabetes mellitus
Intensive care medicine
Cardiology
Percutaneous coronary intervention
Medicine
Internal medicine
Meta-analysis
Conventional PCI
Randomized controlled trial
Emergency medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations